The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity
The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective in vivo inhibition of th...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 1989-09, Vol.100 (3), p.517-528 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 528 |
---|---|
container_issue | 3 |
container_start_page | 517 |
container_title | Toxicology and applied pharmacology |
container_volume | 100 |
creator | van Ommen, Ben Hendriks, Willem Bessems, Jos G.M. Geesink, Geert Müller, Franz van Bladeren, Peter J. |
description | The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied
in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective
in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by
in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective
in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol.
In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene. |
doi_str_mv | 10.1016/0041-008X(89)90299-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15440171</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0041008X89902998</els_id><sourcerecordid>15440171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</originalsourceid><addsrcrecordid>eNp9kF1rHCEUhiWkpNs0fyCk4EUp7cW06rij3hRK6BcEctEEeieOc8waZnWjbprtr4_TWfayV8p5n3N4eRC6oOQjJbT7RAinDSHy93upPijClGrkEVpQorqGtG17jBYH5CV6lfM9IURxTk_QCROy_toFur9ZAU4wmuJjwD2UPwABlzqMT36o00fAvY8lmZBdTOuZiw6v4MnY1RhT7CH8hQDYhAH7kvEmps1ql3yIdxC8xcbWK77sXqMXzowZzvbvKbr99vXm8kdzdf395-WXq8YuCSvNwKQ1wkEnJBNuGGTPOmasYND2jHMJyjmwtBNcECmYEMYx1Rq1ZIr1PWPtKXo3392k-LCFXPTaZwvjaALEbdZ0yTmhglaQz6BNMecETm-SX5u005ToSbGe_OnJn5ZK_1OsZV17s7-_7dcwHJb2Tmv-dp-bbM3oqjrr8wHrOsqVmrDzGXMmanOXKnL7S9Vikk7VPs8hVFGPHpLO1kOwMPgEtugh-v-XfAaFsKJ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15440171</pqid></control><display><type>article</type><title>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>van Ommen, Ben ; Hendriks, Willem ; Bessems, Jos G.M. ; Geesink, Geert ; Müller, Franz ; van Bladeren, Peter J.</creator><creatorcontrib>van Ommen, Ben ; Hendriks, Willem ; Bessems, Jos G.M. ; Geesink, Geert ; Müller, Franz ; van Bladeren, Peter J.</creatorcontrib><description>The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied
in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective
in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by
in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective
in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol.
In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/0041-008X(89)90299-8</identifier><identifier>PMID: 2789443</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Biotransformation ; Chemical and Drug Induced Liver Injury ; Chemical and industrial products toxicology. Toxic occupational diseases ; Chlorobenzenes - pharmacokinetics ; COMPOSE ORGANOCHLORE ; COMPUESTO ORGANICO DEL CLORO ; Cytochrome P-450 Enzyme Inhibitors ; CYTOCHROME P450 ; CYTOCHROMES ; Female ; FONGICIDE ; FUNGICIDAS ; FUNGICIDES ; Hexachlorobenzene - pharmacokinetics ; Hexachlorobenzene - toxicity ; HYDROQUINONES ; Hydroquinones - metabolism ; In Vitro Techniques ; INHIBITORS ; Liver Diseases - metabolism ; Male ; Medical sciences ; METABOLITE ; METABOLITES ; METABOLITOS ; METALLOPROTEINE ; METALLOPROTEINS ; METALPROTEINAS ; Microsomes, Liver - metabolism ; ORGANOCHLORINE COMPOUNDS ; OXIDACION ; OXIDATION ; Oxidation-Reduction ; OXYDATION ; PCP ; Pentachlorophenol - metabolism ; PORFIRINAS ; Porphyrias - chemically induced ; Porphyrias - metabolism ; PORPHYRINE ; PORPHYRINS ; QUINONAS ; QUINONE ; QUINONES ; RAT ; RATA ; RATS ; Rats, Inbred Strains ; Toxicology ; TRIOCETYLOLEANDOMYCIN ; Troleandomycin - pharmacology ; Various organic compounds</subject><ispartof>Toxicology and applied pharmacology, 1989-09, Vol.100 (3), p.517-528</ispartof><rights>1989</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</citedby><cites>FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0041-008X(89)90299-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6614993$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2789443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Ommen, Ben</creatorcontrib><creatorcontrib>Hendriks, Willem</creatorcontrib><creatorcontrib>Bessems, Jos G.M.</creatorcontrib><creatorcontrib>Geesink, Geert</creatorcontrib><creatorcontrib>Müller, Franz</creatorcontrib><creatorcontrib>van Bladeren, Peter J.</creatorcontrib><title>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied
in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective
in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by
in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective
in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol.
In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Chemical and Drug Induced Liver Injury</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Chlorobenzenes - pharmacokinetics</subject><subject>COMPOSE ORGANOCHLORE</subject><subject>COMPUESTO ORGANICO DEL CLORO</subject><subject>Cytochrome P-450 Enzyme Inhibitors</subject><subject>CYTOCHROME P450</subject><subject>CYTOCHROMES</subject><subject>Female</subject><subject>FONGICIDE</subject><subject>FUNGICIDAS</subject><subject>FUNGICIDES</subject><subject>Hexachlorobenzene - pharmacokinetics</subject><subject>Hexachlorobenzene - toxicity</subject><subject>HYDROQUINONES</subject><subject>Hydroquinones - metabolism</subject><subject>In Vitro Techniques</subject><subject>INHIBITORS</subject><subject>Liver Diseases - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>METABOLITE</subject><subject>METABOLITES</subject><subject>METABOLITOS</subject><subject>METALLOPROTEINE</subject><subject>METALLOPROTEINS</subject><subject>METALPROTEINAS</subject><subject>Microsomes, Liver - metabolism</subject><subject>ORGANOCHLORINE COMPOUNDS</subject><subject>OXIDACION</subject><subject>OXIDATION</subject><subject>Oxidation-Reduction</subject><subject>OXYDATION</subject><subject>PCP</subject><subject>Pentachlorophenol - metabolism</subject><subject>PORFIRINAS</subject><subject>Porphyrias - chemically induced</subject><subject>Porphyrias - metabolism</subject><subject>PORPHYRINE</subject><subject>PORPHYRINS</subject><subject>QUINONAS</subject><subject>QUINONE</subject><subject>QUINONES</subject><subject>RAT</subject><subject>RATA</subject><subject>RATS</subject><subject>Rats, Inbred Strains</subject><subject>Toxicology</subject><subject>TRIOCETYLOLEANDOMYCIN</subject><subject>Troleandomycin - pharmacology</subject><subject>Various organic compounds</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1rHCEUhiWkpNs0fyCk4EUp7cW06rij3hRK6BcEctEEeieOc8waZnWjbprtr4_TWfayV8p5n3N4eRC6oOQjJbT7RAinDSHy93upPijClGrkEVpQorqGtG17jBYH5CV6lfM9IURxTk_QCROy_toFur9ZAU4wmuJjwD2UPwABlzqMT36o00fAvY8lmZBdTOuZiw6v4MnY1RhT7CH8hQDYhAH7kvEmps1ql3yIdxC8xcbWK77sXqMXzowZzvbvKbr99vXm8kdzdf395-WXq8YuCSvNwKQ1wkEnJBNuGGTPOmasYND2jHMJyjmwtBNcECmYEMYx1Rq1ZIr1PWPtKXo3392k-LCFXPTaZwvjaALEbdZ0yTmhglaQz6BNMecETm-SX5u005ToSbGe_OnJn5ZK_1OsZV17s7-_7dcwHJb2Tmv-dp-bbM3oqjrr8wHrOsqVmrDzGXMmanOXKnL7S9Vikk7VPs8hVFGPHpLO1kOwMPgEtugh-v-XfAaFsKJ8</recordid><startdate>19890915</startdate><enddate>19890915</enddate><creator>van Ommen, Ben</creator><creator>Hendriks, Willem</creator><creator>Bessems, Jos G.M.</creator><creator>Geesink, Geert</creator><creator>Müller, Franz</creator><creator>van Bladeren, Peter J.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19890915</creationdate><title>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</title><author>van Ommen, Ben ; Hendriks, Willem ; Bessems, Jos G.M. ; Geesink, Geert ; Müller, Franz ; van Bladeren, Peter J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-d28ca7fe67827fdd8b262ac72e3b2448e9ffec16747087277af293a95292bb223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Chemical and Drug Induced Liver Injury</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Chlorobenzenes - pharmacokinetics</topic><topic>COMPOSE ORGANOCHLORE</topic><topic>COMPUESTO ORGANICO DEL CLORO</topic><topic>Cytochrome P-450 Enzyme Inhibitors</topic><topic>CYTOCHROME P450</topic><topic>CYTOCHROMES</topic><topic>Female</topic><topic>FONGICIDE</topic><topic>FUNGICIDAS</topic><topic>FUNGICIDES</topic><topic>Hexachlorobenzene - pharmacokinetics</topic><topic>Hexachlorobenzene - toxicity</topic><topic>HYDROQUINONES</topic><topic>Hydroquinones - metabolism</topic><topic>In Vitro Techniques</topic><topic>INHIBITORS</topic><topic>Liver Diseases - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>METABOLITE</topic><topic>METABOLITES</topic><topic>METABOLITOS</topic><topic>METALLOPROTEINE</topic><topic>METALLOPROTEINS</topic><topic>METALPROTEINAS</topic><topic>Microsomes, Liver - metabolism</topic><topic>ORGANOCHLORINE COMPOUNDS</topic><topic>OXIDACION</topic><topic>OXIDATION</topic><topic>Oxidation-Reduction</topic><topic>OXYDATION</topic><topic>PCP</topic><topic>Pentachlorophenol - metabolism</topic><topic>PORFIRINAS</topic><topic>Porphyrias - chemically induced</topic><topic>Porphyrias - metabolism</topic><topic>PORPHYRINE</topic><topic>PORPHYRINS</topic><topic>QUINONAS</topic><topic>QUINONE</topic><topic>QUINONES</topic><topic>RAT</topic><topic>RATA</topic><topic>RATS</topic><topic>Rats, Inbred Strains</topic><topic>Toxicology</topic><topic>TRIOCETYLOLEANDOMYCIN</topic><topic>Troleandomycin - pharmacology</topic><topic>Various organic compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Ommen, Ben</creatorcontrib><creatorcontrib>Hendriks, Willem</creatorcontrib><creatorcontrib>Bessems, Jos G.M.</creatorcontrib><creatorcontrib>Geesink, Geert</creatorcontrib><creatorcontrib>Müller, Franz</creatorcontrib><creatorcontrib>van Bladeren, Peter J.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Ommen, Ben</au><au>Hendriks, Willem</au><au>Bessems, Jos G.M.</au><au>Geesink, Geert</au><au>Müller, Franz</au><au>van Bladeren, Peter J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>1989-09-15</date><risdate>1989</risdate><volume>100</volume><issue>3</issue><spage>517</spage><epage>528</epage><pages>517-528</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>The relation between the major toxic effect of hexachlorobenzene, hepatic porphyria, and its oxidative biotransformation was studied
in vivo, by observing the effect of modulating its biotransformation on the expression of porphyria. This modulation was achieved by selective
in vivo inhibition of the major cytochrome P450 isoenzyme involved in both the hydroxylation of hexachlorobenzene and its primary oxidative metabolite, pentachlorophenol. The involvement of this isoenzyme, cytochrome P450p, was established by
in vitro biotransformation studies using microsomes derived from rats treated with various inducers of cytochrome P450 isoenzymes and selective
in vitro inactivation of cytochrome P450p by triacetyloleandomycin (TAO), resulting in a strong inhibition of the microsomal conversion of hexachlorobenzene and pentachlorophenol.
In vivo inactivation of cytochrome P450p was achieved by coadministration of hexachlorobenzene and TAO. Female rats which were treated with this diet for 10 weeks showed a strongly diminished urinary excretion of the major oxidative metabolites, pentachlorophenol and tetrachloro-1,4-hydroquinone, as compared to rats treated with hexachlorobenzene alone. The TAO coadministration was found to result in complexation of 70% of the total amount of hepatic microsomal cytochrome P450. The group treated with hexachlorobenzene alone displayed a 600-fold increase in the amount of hepatic porphyrins, whereas an almost complete absence of hepatic porphyrins was observed after administration of hexachlorobenzene together with TAO. The urinary excretion of porphyrins was also significantly lowered by cotreatment with TAO. A strong correlation was found to exist between the amount of porphyrins excreted and the amount of oxidative metabolites excreted, as a function of exposure time. Glucuronidation of pentachlorophenol was observed to an average extent of 30%. This percentage was not influenced by either TAO or phenobarbital. These results suggest that oxidative biotransformation, and thus the formation of the very reactive tetrachloro-1,4-benzoquinone, is directly related to the porphyrinogenic action of hexachlorobenzene.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>2789443</pmid><doi>10.1016/0041-008X(89)90299-8</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 1989-09, Vol.100 (3), p.517-528 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_proquest_miscellaneous_15440171 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Biological and medical sciences Biotransformation Chemical and Drug Induced Liver Injury Chemical and industrial products toxicology. Toxic occupational diseases Chlorobenzenes - pharmacokinetics COMPOSE ORGANOCHLORE COMPUESTO ORGANICO DEL CLORO Cytochrome P-450 Enzyme Inhibitors CYTOCHROME P450 CYTOCHROMES Female FONGICIDE FUNGICIDAS FUNGICIDES Hexachlorobenzene - pharmacokinetics Hexachlorobenzene - toxicity HYDROQUINONES Hydroquinones - metabolism In Vitro Techniques INHIBITORS Liver Diseases - metabolism Male Medical sciences METABOLITE METABOLITES METABOLITOS METALLOPROTEINE METALLOPROTEINS METALPROTEINAS Microsomes, Liver - metabolism ORGANOCHLORINE COMPOUNDS OXIDACION OXIDATION Oxidation-Reduction OXYDATION PCP Pentachlorophenol - metabolism PORFIRINAS Porphyrias - chemically induced Porphyrias - metabolism PORPHYRINE PORPHYRINS QUINONAS QUINONE QUINONES RAT RATA RATS Rats, Inbred Strains Toxicology TRIOCETYLOLEANDOMYCIN Troleandomycin - pharmacology Various organic compounds |
title | The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A53%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20relation%20between%20the%20oxidative%20biotransformation%20of%20hexachlorobenzene%20and%20its%20porphyrinogenic%20activity&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=van%20Ommen,%20Ben&rft.date=1989-09-15&rft.volume=100&rft.issue=3&rft.spage=517&rft.epage=528&rft.pages=517-528&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1016/0041-008X(89)90299-8&rft_dat=%3Cproquest_cross%3E15440171%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15440171&rft_id=info:pmid/2789443&rft_els_id=0041008X89902998&rfr_iscdi=true |